Combining magnetism and light to fight cancer
By combining, in a liposome1, magnetic nanoparticles and photosensitizers that are
simultaneously and remotely activated by external physical stimuli (a magnetic field and light),
scientists at the Laboratoire Matière et Systèmes Complexes (CNRS/Université Paris Diderot) and
the Laboratoire Physicochimie des Electrolytes et Nanosystèmes Interfaciaux (CNRS/UPMC),2
obtained total tumor regression in mice. Non-toxic when they are not activated, such therapies can
also achieve a reduction in adverse effects. These results, which demonstrate the importance of
multiple treatments, were published in ACS Nano on 24 March 2015.
One of the strategies employed to limit the adverse effects of cancer therapies is the development of
nanocarrier systems that can convey active ingredients to target tumor cells. These are referred to as
“physical” therapies when the active substances, molecules or nanoparticles, can be remotely activated by
external physical stimuli — in this case by light or a magnetic field. In this context, the study team
developed a new type of carrier that combines photosensitivity and magnetism. To achieve this, they first
encapsulated magnetic nanoparticles in the inner compartment of a liposome in sufficient quantities to
render it ultra-magnetic, before incorporating photosensitizers into its lipid bilayer, while preserving an
optimum size for circulation in the blood.
These liposomes, containing magnetic nanoparticles and photosensitizers, were injected directly into the
tumor in the mouse model. The scientists thus combined two techniques to achieve complete destruction
of cancer cells. The first one, magnetic hyperthermia, consists in exciting the nanoparticles with a magnetic
field to raise the temperature of the tumor and destroy it. The second method, photodynamic therapy, is
made possible by the photosensitizers, which, when activated, release reactive oxygen species3 that are
toxic to tumor cells. These two physical therapies act in synergy on the activity of the proteins involved in
apoptosis, or programmed cell death. Their combination thus induces total regression of the tumor, while a
single therapy is not able to stop its growth.
1A liposome is an artificial vesicle whose internal compartment is formed by lipid bilayers.
2In collaboration with scientists from the Paris-Centre de Recherche Cardiovasculaire (Inserm/Université Paris Descartes)
3Reactive oxygen species are oxygenated chemical species such as free radicals. In this case, activation of the photosensitizer
causes the formation of a particular state of the oxygen molecule, which is chemically very reactive and hence highly toxic.
For the research team, the next stage consists in exploiting the “other” magnetic properties of liposomes in
order to improve the treatment: nanoparticles are indeed visible under MRI and can be shifted using
magnets. After an injection into the bloodstream, it would therefore become possible to use the magnets to
target the liposomes towards the tumors, while mapping their final destination by MRI.
Combining Magnetic Hyperthermia and Photodynamic Therapy for Tumor Ablation with
Photoresponsive Magnetic Liposomes
Riccardo Di Corato, Gaëlle Béalle, Jelena Kolosnjaj-Tabi, Ana Espinosa, Olivier Clément, Amanda K. A.
Silva, Christine Ménager, et Claire Wilhelm. ACS nano, 24 March 2015. DOI : 10.1021/nn506949t.
Scientist l Claire Wilhelm l T 01 57 27 62 53 l email@example.com
Scientistl Christine Ménager l T 01 44 27 30 47 l firstname.lastname@example.org
CNRS press l Alexiane Agullo l T 01 44 96 43 90 l email@example.com
Masson’s trichrome staining: the cell nuclei are blue-black, the
cytoplasms (cell bodies) are mauve and the collagen fibers are
© Riccardo Di Corato – laboratoire MSC (CNRS/Université Paris